Literature DB >> 8447825

Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism.

H Fabian1, G I Szendrei, H H Mantsch, L Otvos.   

Abstract

The 42 amino acid beta A4 peptide is the major constituent of the senile plaques, one of the hallmark neuropathological lesions of Alzheimer's disease. While C-terminally truncated variants were shown to be present in normal body fluids, a single Glu-->Gln change in the 39 amino acid form of beta A4 results in accelerated fibril formation in the brains of patients with Dutch-type hereditary cerebral hemorrhage with amyloidosis. In this study we used Fourier-transform infrared and circular dichroism spectroscopies on synthetic peptides to demonstrate that this mutation results in altered secondary structure in membrane mimicking solvents, characterized by a considerably higher beta-structure content for the mutant peptide. Moreover, extreme high and low pH were less effective in eliminating the beta-conformation for the Dutch-variant than for the normal human sequence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447825     DOI: 10.1006/bbrc.1993.1207

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.

Authors:  M von Bergen; P Friedhoff; J Biernat; J Heberle; E M Mandelkow; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Protein engineering as a strategy to avoid formation of amyloid fibrils.

Authors:  V Villegas; J Zurdo; V V Filimonov; F X Avilés; C M Dobson; L Serrano
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity.

Authors:  Jijun Dong; Jeffrey M Canfield; Anil K Mehta; Jacob E Shokes; Bo Tian; W Seth Childers; James A Simmons; Zixu Mao; Robert A Scott; Kurt Warncke; David G Lynn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

4.  Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein.

Authors:  D J Watson; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.

Authors:  C Soto; E M Castaño
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

7.  Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach.

Authors:  Somdutta Sen; Debasis Dash; Santosh Pasha; Samir K Brahmachari
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

8.  Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

Authors:  O M El-Agnaf; G B Irvine; G Fitzpatrick; W K Glass; D J Guthrie
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

Review 9.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

10.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

Authors:  E M Castano; F Prelli; T Wisniewski; A Golabek; R A Kumar; C Soto; B Frangione
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.